subscribe banner image

Sleep & Respiratory Newsletter

December 2017

In this issue

Consider every breath: AVAPS therapy & the chronic disease sufferer


Average Volume Assured Pressure Support (AVAPS) therapy technology1 is designed to provide consistent tidal volume – e.g. volume of inhaled air – at the lowest minimum inspiratory pressure. AVAPS therapy maintains the low pressure required to achieve the prescribed tidal volume, with each and every breath. Patients can enjoy enhanced comfort and the confidence that the therapy is working effectively. 


This article explores how hybrid mode AVAPS can be an effective therapy for chronic disease sufferers, whose disease progression and needs evolve. 

News & topics

Philips launches global education and empowerment effort for World COPD Day

Philips announces strategic alliance with IncreMedical

Philips Capital Markets Day 2017

COPD Insider Newsletter

Register now for exclusive monthly content for COPD professionals

Sleep & Respiratory Newsletter

Want to get more sleep and respiratory articles, news and information from Philips?

Tell us what you think


Philips & World COPD Day 2017: there’s always a way to make life better


Chronic obstructive pulmonary disease (COPD) is a common, often underdiagnosed, and debilitating disease.  It is fourth leading cause of death worldwide and is estimated to be the third leading cause by 20202, and yet, there is still a lack of awareness and a social stigma associated with the disease.


Philips is committed to sustaining the education and moral support of patients, families and care givers impacted by COPD. Recently Philips joined forces with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) to support World COPD Day.


This year, Philips joined forces with with Russell Winwood and his physician to help educate, engage and empower COPD patients and their caregivers. Russell Winwood, a COPD patient and advocate, shares his personal journey with other COPD patients to inspire them to live their lives to the fullest.

Happenings is a look at some of the exciting and empowering goings-on in the world of sleep and respiratory care.

Tech Spotlight

InnoSpire Go. More time for life.


Philips InnoSpire Go is a virtually silent, handheld nebulizer designed as a fast, convenient, and portable treatment option for the rising population of both children and adults with chronic respiratory conditions. InnoSpire Go simplifies the delivery of inhaled medication, offering fast and effective four-minute treatment3, reducing treatment time by 25%4.

Innospire Go gold award 2016


2Global Initiative for Chronic Obstructive Lung Disease. 2017. Retrieved from:

3Using 2.5ml Salbutamol. Data on file.

4Versus predecessor, Aeroneb Go. Data on file.

You are about to visit a Philips global content page


You are about to visit a Philips global content page


Our site can best be viewed with the latest version of Microsoft Edge, Google Chrome or Firefox.